Drug intelligence / Profile preview

ampicillin + procaine

Development stage
Unknown
Lead developer
Astrum Healthcare
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Ampicillin + procaine is a combination pharmaceutical consisting of the aminopenicillin antibiotic ampicillin and the local anesthetic procaine. Ampicillin is a beta-lactam antibiotic that exerts its bactericidal activity by binding to penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. This binding inhibits the transpeptidation enzymes responsible for cross-linking peptidoglycan chains, leading to cell wall instability and osmotic lysis. Procaine is an ester-type local anesthetic that is typically included in injectable formulations to mitigate the pain associated with intramuscular administration. It functions by binding to and inhibiting voltage-gated sodium channels on the neuronal membrane, thereby preventing the initiation and conduction of nerve impulses. This combination is primarily utilized in veterinary medicine for the treatment of systemic infections caused by susceptible Gram-positive and Gram-negative bacteria, where the addition of procaine facilitates the administration of large-volume doses.

Brand names
AmpiprocProcaine Ampicillin
Other names
ampicillin procaineprocaine ampicillin
02

Targets

PBP (Penicillin-binding protein family)SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)ADRB1 (β1)

Beyond the preview

Go deeper on ampicillin + procaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ampicillin + procaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call